Patrick Machado - 01 Oct 2021 Form 3 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Director
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Patrick Machado
Issuer symbol
ROIV
Transactions as of
01 Oct 2021
Net transactions value
$0
Form type
3
Filing time
01 Oct 2021, 17:43:55 UTC
Previous filing
25 Jun 2021
Next filing
14 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ROIV Stock Option (Right to Buy) 01 Oct 2021 Common Shares 170,167 $5.19 Direct F1
holding ROIV Stock Option (Right to Buy) 01 Oct 2021 Common Shares 109,732 $7.43 Direct F1
holding ROIV Stock Option (Right to Buy) 01 Oct 2021 Common Shares 109,732 $11.19 Direct F2, F5
holding ROIV Stock Option (Right to Buy) 01 Oct 2021 Common Shares 109,732 $12.68 Direct F3, F5
holding ROIV Stock Option (Right to Buy) 01 Oct 2021 Common Shares 109,732 $10.00 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of stock options to purchase Common Shares that is fully vested.
F2 Award of stock options to purchase Common Shares with a vesting commencement date of November 30, 2018.
F3 Award of stock options to purchase Common Shares with a vesting commencement date of November 30, 2019.
F4 Award of stock options to purchase Common Shares with a vesting commencement date of December 27, 2019.
F5 Awards of stock options to purchase Common Shares vest and become exercisable (i) 33% on the first anniversary of the applicable vesting commencement date and (ii) in 24 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.

Remarks:

Exhibit 24 - Power of Attorney